Production d'Insuline Humaine Recombinante

La biotechnologie rencontre la fabrication pharmaceutique

Pharmaceutical & Drug Manufacturing Global Industrial Scale $35 billion

Aperçu

Recombinant human insulin is produced using genetically engineered Escherichia coli or Saccharomyces cerevisiae that express the human insulin gene. This biotechnological process replaced the previous method of extracting insulin from pig and cow pancreases, providing unlimited supply with reduced immunogenicity. The process involves fermentation, cell lysis, inclusion body solubilization, refolding, enzymatic modification, and multi-step chromatographic purification to produce pharmaceutical-grade insulin.

Procédé chimique

E. coli expressing proinsulin genes are fermented in large bioreactors. Inclusion bodies containing proinsulin are isolated, solubilized in urea, and the protein is refolded by controlled oxidation. Trypsin and carboxypeptidase B cleave the C-peptide to yield mature insulin, which is purified by reversed-phase and ion-exchange chromatography.

Proinsulin →[Trypsin + Carboxypeptidase B] Insulin (A-chain + B-chain linked by disulfide bonds) + C-peptide

Matières premières

  • Glucose (C₆H₁₂O₆) — Corn processing (Carbon source for fermentation)
  • Ammonium sulfate ((NH₄)₂SO₄) — Chemical synthesis (Nitrogen source)
  • Trypsin (enzyme) — Recombinant production (C-peptide cleavage)

Produits finis

  • Recombinant human insulin — Diabetes treatment (>98% purity, multiple analog forms)
<path stroke-linecap="round" stroke-linejoin="round" d="M12 9v3.75m-9.303 3.376c-.866 1.5.217 3.374 1.948 3.374h14.71c1.73 0 2.813-1.874 1.948-3.374L13.949 3.378c-.866-1.5-3.032-1.5-3.898 0L2.697 16.126zM12 15.75h.007v.008H12v-.008z" />

Environmental Impact

Fermentation-based production generates biological waste requiring sterilization before disposal. Chromatographic purification consumes significant water and buffer solutions. However, the environmental impact is far less than animal-sourced insulin which required millions of animal pancreases annually.

Considérations de sécurité

Innovations récentes

Insulin analogs (lispro, glargine, aspart) with modified amino acid sequences provide faster or longer-acting profiles.
Cell-free protein synthesis and oral insulin delivery systems are in advanced development stages.

Plus dans Pharmaceutical & Drug Manufacturing

Production de Pénicilline G par Fermentation

Global Industrial Scale

Production Semi-Synthétique d'Amoxicilline

Global Industrial Scale

Synthèse de l'Aspirine par Acétylation de l'Acide Salicylique

Global Industrial Scale

Synthèse de l'Ibuprofène — Procédé Vert BHC

Global Industrial Scale

Synthèse de l'Oméprazole pour les Inhibiteurs de la Pompe à Protons

Global Industrial Scale

Synthèse du Chlorhydrate de Metformine

Global Industrial Scale

Synthèse du Paracétamol (Acétaminophène)

Global Industrial Scale

Frequently Asked Questions

What industry uses Production d'Insuline Humaine Recombinante?
Production d'Insuline Humaine Recombinante is used in the pharmaceutical & drug manufacturing sector at global industrial scale scale.
What process is involved in Production d'Insuline Humaine Recombinante?
E. coli expressing proinsulin genes are fermented in large bioreactors. Inclusion bodies containing proinsulin are isolated, solubilized in urea, and the protein is refolded by controlled oxidation. Trypsin and carboxypeptidase B cleave the C-peptide to yield mature insulin, which is purified by rev
What is the economic significance of Production d'Insuline Humaine Recombinante?
Production d'Insuline Humaine Recombinante has a market value of $35 billion.
What is the environmental impact of Production d'Insuline Humaine Recombinante?
Fermentation-based production generates biological waste requiring sterilization before disposal. Chromatographic purification consumes significant water and buffer solutions. However, the environmental impact is far less than animal-sourced insulin which required millions of animal pancreases annua
What raw materials are used in Production d'Insuline Humaine Recombinante?
The main raw materials include: Glucose (C₆H₁₂O₆), Ammonium sulfate ((NH₄)₂SO₄), Trypsin (enzyme).